[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346169-105":59,"doc-detail-346169-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","differential-cancer-risks-and-noninvasive-predictors-in-masld-metald-and-ald-a-longitudinal-analysis","Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, and ALD - A Longitudinal Analysis","","Long-term cancer risk is incompletely characterized across the steatotic liver disease (SLD) phenotypes: metabolic dysfunction-associated SLD (MASLD), MASLD with increased alcohol intake (MetALD), and alcohol-related liver disease (ALD). A longitudinal cohort of 43,994 adults followed for a median 10.5 years assessed liver steatosis by ultrasonography and used FIB-4 and SAFE as noninvasive predictors. Overall cancer risk rose in ALD, hepatocellular carcinoma risk increased across SLD, and fibrosis indices showed dose-response with attenuation after age adjustment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/differential-cancer-risks-and-noninvasive-predictors-in-masld-metald-and-ald-a-longitudinal-analysis/346169/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/differential-cancer-risks-and-noninvasive-predictors-in-masld-metald-and-ald-a-longitudinal-analysis/346169.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What steatotic liver disease phenotypes were compared in this study?","Question",{"text":112,"@type":113},"The study compared MASLD, MASLD with increased alcohol intake (MetALD), and alcohol-related liver disease (ALD).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were predictors of cancer incidence evaluated?",{"text":117,"@type":113},"Liver steatosis was diagnosed by ultrasonography, and noninvasive fibrosis predictors were assessed using FIB-4 and SAFE scores.",{"name":119,"@type":110,"acceptedAnswer":120},"Which phenotype carried the highest cancer burden?",{"text":121,"@type":113},"Alcohol-related phenotypes carried the highest burden, with elevated overall cancer risk observed in ALD and increased hepatocellular carcinoma risk across SLD groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346169,1790146389,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Gut and Liver  \n[https://doi.org/10.5009/gnl260186](https://doi.org/10.5009/gnl260186)[ ](https://doi.org/10.5009/gnl260186)[pISSN 1976-2283 eISSN 2005-1212](pISSN 1976-2283 eISSN 2005-1212)  \nOriginal Article  \n\n| Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, andALD: A Longitudinal Analysis\u003Cbr>Hana Park1 , Ji Young Lee2 , Ja Eun Koo2 , Jong Soo Lee2 , Sungwon Park3 , Hye Won Park2 , Hye-Sook Chang2 , Hong-Kyu Kim4 , Jaewon Choe2,5 , Ju Hyun Shim5,6\u003Cbr>1Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea; 2Division of Gastroenterology, Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 3Division of Radiology, Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 4Division of Endocrinology, Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 5Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 6Liver Cancer Center, Asan Medical Center Cancer Institute, University of Ulsan College of Medicine, Seoul, Korea |  |  |\n| --- | --- | --- |\n| Article Info\u003Cbr>Received April 17, 2026\u003Cbr>Revised July 19, 2026\u003Cbr>Accepted July 21, 2026\u003Cbr>Published online September 15, 2026\u003Cbr>Corresponding Author\u003Cbr>Hana Park\u003Cbr>ORCID [https://orcid.org/0000-0001-8449-034X](https://orcid.org/0000-0001-8449-034X)[E-mail](E-mail hnpark80@gmail.com)[ hnpark80@gmail.com](E-mail hnpark80@gmail.com)\u003Cbr>Ju Hyun Shim\u003Cbr>ORCID [https://orcid.org/0000-0002-7336-1371](https://orcid.org/0000-0002-7336-1371)[ ](https://orcid.org/0000-0002-7336-1371)[E-mail](E-mail s5854@amc.seoul.kr)[ s5854@amc.seoul.kr](E-mail s5854@amc.seoul.kr) | Background/Aims: The recently proposed classification of steatotic liver disease (SLD) comprises metabolic dysfunction-associated steatotic liver disease (MASLD), MASLD with increased alcohol intake (MetALD), and alcohol-related liver disease (ALD) . Long-term cancer risk across these phenotypes remains incompletely characterized, and was investigated in this study. Methods: This longitudinal cohort study included 43,994 adults who underwent health check-upsin 2010–2011. Liver steatosis was diagnosed by ultrasonography. The Fibrosis-4 (FIB-4) and steatosis-associated fibrosis estimator (SAFE) scores were evaluated as predictors of cancer incidence.\u003Cbr>Results: Over a median 10.5 years (398,202 person-years), 3,169 cancers occurred (795 .8 per 100,000 person-years) . Versus no SLD, overall cancer risk was elevated in ALD (incidence rate ratio [IRR], 1.38; 95% confidence interval, 1.08 to 1.79) but not MASLD or MetALD. Hepatocellular carcinoma risk increased across all SLD groups, most strongly in the MetALD and ALD groups, with a more modest association in the MASLD group that was attenuated in sensitivity analyses. ALD was associated with an elevated risk of esophageal cancer (IRR, 5 .98) and stomach cancer (IRR, 2 .41), and MetALD with an increased risk of stomach cancer (IRR, 1.61) . FIB-4 and SAFE showed dose–response associations with cancer that were substantially attenuated after age adjustment, persisting mainly at the highest categories.\u003Cbr>Conclusions: Cancer risk differs across MASLD, MetALD, and ALD, with alcohol-related phenotypes carrying the highest burden. Noninvasive fibrosis indices such as FIB-4 and SAFE may help stratify risk—though largely age-related—and could inform risk-based surveillance in SLD.\u003Cbr>(Gut Liver, 2026;20:880-892)\u003Cbr>Key Words: Fatty liver; Liver diseases; Alcohol; Alcohol drinking; Neoplasms |  |\n| \u003Cbr>INTRODUCTION |  | this framework, the relationship between MASLD and hepatocellular carcinoma (HCC) risk has been increasingly |\n| The recently introduced steatotic liver disease (SLD) |  | characterized,4 underscoring the need to delineate cancer |\n| framework, encompassing metabolic dysfunction-asso- |  | r","cbCaimfcx8NrANHi","https://ap.wps.com/l/cbCaimfcx8NrANHi","pdf",425421,13,"English","# Background/Aims\n# Methods\n# Results\n# Conclusions\n## Key words","[{\"question\":\"What steatotic liver disease phenotypes were compared in this study?\",\"answer\":\"The study compared MASLD, MASLD with increased alcohol intake (MetALD), and alcohol-related liver disease (ALD).\"},{\"question\":\"How were predictors of cancer incidence evaluated?\",\"answer\":\"Liver steatosis was diagnosed by ultrasonography, and noninvasive fibrosis predictors were assessed using FIB-4 and SAFE scores.\"},{\"question\":\"Which phenotype carried the highest cancer burden?\",\"answer\":\"Alcohol-related phenotypes carried the highest burden, with elevated overall cancer risk observed in ALD and increased hepatocellular carcinoma risk across SLD groups.\"}]","Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, and ALD - A Longitudinal Analysis | PDF",1790060370,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53a86e8cb4bbd7ffe43f210d01142d64.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75ba380f801f261bc46eb8d2db15c281.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5085e3b60803b9d5438963a279ac6ab4.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ee3382a61c49d04b86cfeef47d7064f.webp",980,1306]